Person

Thomas W. Hofmann

Formerly Director, West Pharmaceutical Services

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$1.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 10, 2024WSTSale617$365.92$226K
May 1, 2023WSTSale1,212$365.58$443K
May 25, 2016WSTSale2,466$73.57$181K
Feb 29, 2016WSTSale3,042$62.70$191K

SEC reporting-owner ID (CIK) 1174597 · all filings on EDGAR